Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-087545

Chief Operating Officer gave up 6,250 shares (to pay taxes)

  • Chief Operating Officer acquired 12,306 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BILINSKY IGOR Chief Operating Officer 2025-09-02 Option exercise +12,306 105,939 D
BILINSKY IGOR Chief Operating Officer 2025-09-02 Shares withheld for taxes −6,250 $2.19 $13,688 99,689 D
Derivatives
BILINSKY IGOR Chief Operating Officer 2025-09-02 Option exercise · Restricted Stock Units −3,516 7,033 D
BILINSKY IGOR Chief Operating Officer 2025-09-02 Option exercise · Restricted Stock Units −8,790 52,738 D
Loading xslF345X05/tm2525186-1_4seq1.xml…